Matthew Dodds
Matthew Dodds
boston earnings flat growth half overall percent portfolio restore sales second slip together until year
Boston's overall sales growth is going to slip to 5 percent in the second half of this year and go flat in 2006. The new-product portfolio Boston is piecing together can restore double-digit earnings and sales growth, but it will probably take until 2009.
board company damaged destroying value
They are destroying the value of their company for a damaged asset. What is their board thinking?
board boston components extra issues
Even with the new components of the Boston offer, we don't think Guidant's board will get comfortable enough with the aforementioned antitrust issues and the extra $1.
boston dominate johnson market seems
It seems like (Johnson & Johnson and Boston Scientific) are going to dominate the market at least through '06.
boston complete couple due needed scientific weeks
Boston Scientific has a couple of more weeks if needed to complete due diligence.
committed fully odds stopping
The odds of them stopping this are not high. They are fully committed to walking.
million problem trouble walked
They walked away, and they got $700 million for their trouble. I don't really see a problem here.